Canada: Healthcare System and Drug Regulatory Overview

The pricing and reimbursement process in Canada is considered to be challenging to pharma, and although the Patented Medicines Prices Review Board, the Common Drug Review, and the public drug plans have their distinct strategies for regulating drug prices, there is substantial variation in reimbursement between provinces.

In terms of the drug approval process, Health Canada takes longer to award marketing approval for new drugs than the European Medicines Agency (EMA). Consequently, in order to speed up the process, user fees were increased in April 2011, and from April 2012 all fees will be increased annually by 2%.

Canada lacks any workable right of appeal under its linkage system and it is the only G7 nation that does not offer any form of patent term restoration. Because of this, Canada is on the PhRMA Special 301 Watch List and major reform of the intellectual property system has been called for.

Request a Sample for or Inquire before buying the report @
http://www.reportsnreports.com/reports/144094-canada-healthcare-system-and-drug-regulatory-overview.html

Features and benefits
• Assess the key factors facing pharma in terms of regulatory issues, pricing and reimbursement.
• Review the insurance and healthcare system in Canada including recent health reforms.
• Gain insight into regulatory and intellectual property issues in Canada.
• Review important pricing and reimbursement issues in Canada.

The pricing and reimbursement process in Canada is considered to be challenging to pharma. Furthermore, Health Canada takes longer to award marketing approval for new drugs than the European Medicines Agency (EMA). Also, while the intellectual property environment in Canada has improved in recent years, it is still considered to be behind that of other G7 countries.

Explore Table of Contents available in the report Canada: Healthcare System and Drug Regulatory Overview.

Market and Product Forecasts: COPD in China – Novel therapies to see patient potential limited by high cost

The increasing prevalence of COPD and new therapies will boost the Chinese COPD market from $204m to $317m by 2020. Spiriva will become the market leader from 2013 and maintain the position through 2020, owing to its wide application across all disease severities. A number of novel products will increase the product offering on the market, with most pipeline products aimed at more severe patients.

Request a Sample for or Inquire before buying the report @
http://www.reportsnreports.com/reports/144096-market-and-product-forecasts-copd-in-china-novel-therapies-to-see-patient-potential-limited-by-high-cost.html

Features and benefits
• Access Datamonitor’s patient-based COPD market forecast in China, with transparent methodology and clear assumptions.
• Explore the current and future market size of COPD in China and see which key brands will impact the market.
• Gain insight into COPD market dynamics, and see where untapped market potential remains.
• Understand which factors are driving growth in the Chinese COPD market, and what challenges pipeline products face.

Highlights
Datamonitor forecasts the Chinese COPD market to increase from $204m in 2011 to $317m by 2020, at a compound annual growth rate (CAGR) over 2011–20 of 5.0%. Market growth will not only be boosted by patients continuing to switch to more convenient, and more expensive, combination drugs, but also by the increasing prevalence of COPD in China.

Datamonitor forecasts that five new therapies will enter the Chinese market over 2011–20, including the first once-daily ICS/LABA combination and LABA/LAMA combinations. While these combinations are clinically attractive, their commercial potential will be restricted by their relatively high price.

Datamonitor estimates that in 2011 Seretide and Spiriva top all brands by achieving $48m and $46m respectively, together capturing 46% of the Chinese COPD market. Spiriva will face competition from several pipeline products after 2013, but its wide clinical application across all disease severities will allow it to maintain its market dominance.

Explore Table of Contents available in the report Market and Product Forecasts: COPD in China – Novel therapies to see patient potential limited by high cost

Healthy 50+ Americans: Trends and Opportunities in the Emerging Wellness Market

Published: April 2011
No. of Pages: 174
Price: $ 3850





This Packaged Facts report focuses on the market potential of the 26 million “Healthy Consumers” who are 50 years old and over and who are pursuing a wellness regime that includes healthy eating and regular exercise. Anchored by boomers who firmly believe that getting older means getting better, Packaged Facts’ Healthy 50+ Americans: Trends and Opportunities in the Emerging Wellness Market offers marketers a look into the future of an America where 50+ consumers will generate an increasingly large share of consumer spending power.

With an aggregate household income of $1 trillion, Healthy 50+ Consumers are prime targets for marketers of a wide range of consumer goods and services. Compared to others in their age group, they have higher household incomes and are more confident about the economy as a whole as well as their own financial futures. Healthy 50+ Consumers shop more often, dine out more regularly and travel more frequently. Healthy 50+ Consumers represent a demanding but lucrative consumer segment. For example, they look for quality when they buy clothes and seek out natural and organic products in the aisles of supermarkets and on the shelves of drug stores.

The report begins with a chapter on trends affecting the 50+ health and wellness consumer market and opportunities generated by Healthy 50+ Consumers and a chapter assessing the size and growth of the Healthy 50+ Consumer market. A chapter detailing the core values of 50+ consumers who aspire to health and wellness is followed by an analysis of the fitness activities and healthy eating habits of Healthy 50+ Consumers and an overview of their health management practices. The report continues with a chapter analyzing the financial status and financial management practices of Healthy 50+ Consumers and a chapter exploring their shopping and buying habits. The report concludes with an in-depth review of the leisure and entertainment choices of Healthy 50+ Consumers.

Browse All: Healthcare Market Research

Market Insights: A Selection From The Report
Women in the Vanguard of March to Wellness
Healthy 50+ Consumers are more likely to be women than men (53% vs. 47%). One reason for the gender disparity lies in the fact that women are more numerous in the 65+ age group as a whole because of the shorter life expectancy of men. [Table 3-2]

However, data compiled by Packaged Facts February 2011 Online Consumer Survey suggest that the preponderance of women among Healthy 50+ Consumers results from factors other than purely demographic ones. As seen in Figure 3-1, regardless of age, women are more likely than men to report that they are consciously pursuing wellness goals.

Entertainment Habits Generate Possibilities
As seen in Chapter 5, "Keeping Fit," and Chapter 9, "Leisure and Entertainment," pursuing wellness after 50 involves a higher level of activity than that associated with other consumers in the 50+ age group. Healthy 50+ Consumers account for 15% of those going to a family
restaurant/steak house in the last 30 days and 16% of those attending a live theater event in the past 12 months. At the same time, Healthy 50+ Consumers view reading as a valuable activity. They account for 13% of those buying books at a bookstore in the past 12 months.[Table 2-10]

Aging Boomers and Wellness Concerns Converge to Shift Thinking about Getting Old
Data compiled by Packaged Facts February 2011 Online Consumer Survey confirm the ongoing shifts in perceptions of aging on the part of 50+ consumers, especially among those committed to pursuing wellness. As seen in Table 2-1, respondents 50 years old and over whose daily routine is significantly affected by wellness goals and concerns are most likely to agree with the proposition "60 is the new 50 and 70 is the new 60." Nearly seven in 10 (68%) of 50+ consumers who are concerned with wellness have stretched their definitions of aging, compared to 58% of the 50+ age group as a whole and 62% of those under the age of 50 who are concerned about wellness in their daily lives.